NANO MRNA Co., Ltd.

A new research alliance with Tokyo-based venture Gene Techno Science (GTS) will give Mochida Pharmaceutical Co. Ltd. an entry route into cell-based therapies, an area receiving strong policy and reg

The independent Tokyo-based asset management company Whiz Partners, Inc. gained renewed attention through its major investment in Axcelead Drug Discovery Partners, Inc., a new Japanese venture formed

Axcelead, the drug discovery platform business spun out from Takeda Pharmaceutical Co. Ltd. ’s discovery research division in Japan last July, will become a fully independent company through a transf

With input from Biomedtracker, Scrip highlights eight of the more interesting late-stage clinical trials due to read out in the next three months. vTv Therapeutics' Azeliragon vTv Therapeutics Inc